Since interaction of HOTAIR with EZH2 is reliant on the former’s functional 5′-domain and its binding to LSD1 requires an intact 3′-domain of HOTAIR, synergistic application of AQB and GSK-LSD1 is expected to result in robust protection against gliomas. This evidence concerns the gene KDM1A and central nervous system cancer.